Sim&Cure Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 68

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 8

Sim&Cure General Information

Description

Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. The company's device is fast and has optimal sizing, virtually evaluates the final position of different sizes and shapes of intracranial implants, and secures the treatment, enabling neurologists to effectively treat patients with neurovascular disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Education and Training Services (B2B)
Corporate Office
  • 95 rue Pierre Flourens, Bâtiment H
  • 34090 Montpellier
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sim&Cure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jan-2022 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 23-May-2019 00.000 00.000 0000 Completed Generating Revenue
4. Early Stage VC 17-Dec-2015 00000 00000 00.000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2015 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator $6.56K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2013 $6.56K $6.56K Completed Generating Revenue
To view Sim&Cure’s complete valuation and funding history, request access »

Sim&Cure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Shares 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00.000
To view Sim&Cure’s complete cap table history, request access »

Sim&Cure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. The company's device is
Other Devices and Supplies
Montpellier, France
68 As of 2024
00.000
0000000000 0 00.000

000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
00000000 0000000
Rancho Santa Margarita, CA
0000 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sim&Cure Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Applied Medical Formerly VC-backed Rancho Santa Margarita, CA 0000 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Sim&Cure Patents

Sim&Cure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020365500-A1 Simulation of the deformation after implantation of an implantable medical device Pending 18-Oct-2019 000000000
US-20220367047-A1 Method for simulating the deformation, after implantation, of an implantable medical device Pending 18-Oct-2019 000000000
EP-4046166-A1 Method for simulating the deformation, after implantation, of an implantable medical device Pending 18-Oct-2019 000000000
FR-3102288-A1 Simulation of the deformation after implantation of an implantable medical device Active 18-Oct-2019 000000000 0
FR-3102288-B1 Simulation of deformation after implantation of an implantable medical device Active 18-Oct-2019 A61B34/10
To view Sim&Cure’s complete patent history, request access »

Sim&Cure Executive Team (6)

Name Title Board Seat
Mathieu Sanchez Ph.D Co-Founder, Chief Executive Officer, President & Director General
Dan Raffi Chief Operating Officer
Dominique Ambard Ph.D Director of Research & Development & Distinguished Engineer
Christophe Chnafa Ph.D Chief Innovation and Strategy Officer
Vincent Costalat Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

Sim&Cure Board Members (6)

Name Representing Role Since
Alexis Frentz Elaia Partners Board Observer 000 0000
Daniel Pilaud Ph.D IT-Translation Board Member 000 0000
Gonzague Issenmann Self Board Member 000 0000
Jean-Nicolas Vernin Self Board Member 000 0000
Samantha Jérusalmy Elaia Partners Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Sim&Cure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sim&Cure Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
NeuroTechnology Investors Venture Capital Minority 000 0000 000000 0
Elaia Partners Venture Capital Minority 000 0000 000000 0
Alexis Frentz Angel (individual) Minority 000 0000 000000 0
IT-Translation Venture Capital Minority 000 0000 000000 0
i-Lab LUISS Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Sim&Cure FAQs

  • When was Sim&Cure founded?

    Sim&Cure was founded in 2013.

  • Who is the founder of Sim&Cure?

    Mathieu Sanchez Ph.D and Vincent Costalat are the founders of Sim&Cure.

  • Who is the CEO of Sim&Cure?

    Mathieu Sanchez Ph.D is the CEO of Sim&Cure.

  • Where is Sim&Cure headquartered?

    Sim&Cure is headquartered in Montpellier, France.

  • What is the size of Sim&Cure?

    Sim&Cure has 68 total employees.

  • What industry is Sim&Cure in?

    Sim&Cure’s primary industry is Other Devices and Supplies.

  • Is Sim&Cure a private or public company?

    Sim&Cure is a Private company.

  • What is Sim&Cure’s current revenue?

    The current revenue for Sim&Cure is 00000.

  • How much funding has Sim&Cure raised over time?

    Sim&Cure has raised $3.89M.

  • Who are Sim&Cure’s investors?

    NeuroTechnology Investors, Elaia Partners, Alexis Frentz, IT-Translation, and i-Lab LUISS are 5 of 8 investors who have invested in Sim&Cure.

  • Who are Sim&Cure’s competitors?

    Applied Medical is a competitor of Sim&Cure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »